Raymond James Maintains Outperform on Crescent Capital BDC, Raises Price Target to $21.5
Raymond James analyst Robert Dodd maintains Crescent Capital BDC (NASDAQ:CCAP) with a Outperform and raises the price target from $20 to $21.5.
Crescent Capital BDC Q3 EPS $0.48 Beats $0.41 Estimate
Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.48 per share which beat the analyst consensus estimate of $0.41 by 17.07 percent. This is a 11.63 percent increase over earnings of $0.43 per share
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.
Recap: Crescent Capital BDC Q2 Earnings
Shares of Crescent Capital BDC (NASDAQ:CCAP) moved higher by 2.1% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share rose 15.22% over the past year to $0.53, which beat the estimate of $0.49.
Crescent Capital BDC Q2 Adj. Net Investment Income $0.53/Share Beats $0.49 Estimate
Crescent Capital BDC (NASDAQ:CCAP) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.49 by 8.16 percent. This is a 15.22 percent increase over earnings of $0.46 per share from
Earnings Scheduled For August 11, 2021
Companies Reporting Before The Bell
• Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter.
Oppenheimer Initiates Coverage On Crescent Capital BDC with Perform Rating
Oppenheimer initiates coverage on Crescent Capital BDC (NASDAQ:CCAP) with a Perform rating.
Earnings Scheduled For May 12, 2021
Companies Reporting Before The Bell
• PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter.